A parenteral injection. Acute allergic reactions; bronchial asthma and asthmatic status; prophylaxis or treatment of thyrotoxic reaction and thyrotoxic crisis; shock, incl. resistant to other therapies; myocardial infarction; acute adrenal insufficiency; cirrhosis of the liver, acute hepatitis, acute hepatic renal insufficiency; poisoning with cauterizing fluids (in order to reduce inflammatory phenomena and prevent scar contractions).

Intraarticular administration: rheumatoid arthritis, spondyloarthritis, post-traumatic arthritis, osteoarthritis (in the presence of pronounced signs of joint inflammation, synovitis).api-cas-52-21-1-prednisolone-acetate-7247762

Pills. Systemic diseases of the connective tissue (systemic lupus erythematosus, scleroderma, nodular periarthritis, dermatomyositis, rheumatoid arthritis); acute and chronic inflammatory joint diseases: gouty and psoriatic arthritis, osteoarthritis (incl. post-traumatic), polyarthritis, shoulder periarthritis, ankylosing spondylitis (Bekhterev’s disease), juvenile arthritis, Still’s syndrome in adults, bursitis, nonspecific tenosynovitis, synovitis and epicondylitis; rheumatic fever, acute rheumocarditis; bronchial asthma; acute and chronic allergic diseases: allergic reactions to drugs and food, serum disease, hives, allergic rhinitis, angioedema, drug eczantema, pollinosis; skin diseases: vesicle, psoriasis, eczema, atopic dermatitis, diffuse neurodermatitis, contact dermatitis (with large skin surface lesions), toxidermia, seborrheic dermatitis, exfoliating dermatitis, toxic epidermal necrolysis (Lyell syndrome), bullous herpetiform dermatitis, malignant exudative erythema (Stevens-Johnson syndrome); cerebral edema. (e.g. against a brain tumour or associated with surgery, radiation therapy or head trauma) after prior parenteral administration; congenital adrenal hyperplasia; primary or secondary adrenal insufficiency (e.g. against a brain tumo012alc-5ml-1-hr-1744292ur or associated with surgery, radiation therapy or head trauma) after prior parenteral administration; congenital adrenal hyperplasia; primary or secondary adrenal insufficiency (e.g. against a brain tumour, associated with surgery, radiotherapy or head trauma). including condition after adrenal removal); kidney diseases of autoimmune genesis (including acute glomerulonephritis), nephrotic syndrome; subacute thyroiditis; diseases of the hematopoiesis organs: agranulocytosis, panmielopathy, autoimmune hemolytic anemia, congenital (erythroid) hypoplastic anemia, acute lympho- and myeloid leukemia, lymphogranulomatosis, myeloma, thrombocytopenic purpura, secondary thrombocytopenia in adults, erythroblastopenia (erythrocytic anemia); lung diseases: acute alveolitis, pulmonary fibrosis, sarcoidosis II-III centuries. Tuberculosis meningitis, tuberculosis of the lungs, aspiration pneumonia (in combination with specific chemotherapy); berylliosis, Leffler’s syndrome (not amenable to other therapy); lung cancer (in combination with cytostatics); multiple sclerosis; gastrointestinal tract diseases (to remove the patient from critical condition): ulcerative colitis, Crohn’s disease, local enteritis; hepatitis; prevention of the reaction of rejection of the graft; hypercalcemia against cancer; nausea and vomiting in cytostatic therapy; allergic eye diseases: allergic corneal ulcers, allergic forms of conjunctivitis; inflammatory eye diseases: sympathetic ophthalmia, severe sluggish anterior and posterior uveitis, optic neuritis.

Ointment: hives, atopic dermatitis, diffuse neurodermatitis, simple chronic lichen (limited neurodermatitis), eczema, seborrheic dermatitis, discoidal lupus erythematosus, simple and allergic dermatitis, toxicodermia, erythroderma, psoriasis, alopecia; epicondylitis, tendosynovitis, bursitis, brachial periarthritis, keloid scars, ischialgia.

Eye drops: non-inflammatory diseases of the anterior segment of the eye – iritis, iridocyclitis, uveitis, episcleritis, scleritis, conjunctivitis, parenchymatous and discoid keratitis without damaging the corneal epithelium, allergic conjunctivitis, blepharoconjunctivitis, inflammatory processes after eye injuries and surgical interventions, sympathetic ophthalmia.

Hypersensitivity (the only contraindication for short-term system applications is for life indications).

4 Thoughts to “Use of Prednisolone”

  1. Asking questions are really good thing if you are not understanding anything fully, however this piece of writing offers good understanding even. Chicky Courtnay Handel

  2. At this time it sounds like Movable Type is the best blogging platform out there right now. Selena Paten Leon

  3. I regard something really interesting about your website so I saved to fav. Inesita Andreas Yvor

  4. I really enjoy the blog article. Really looking forward to read more. Great. Tybi Fremont Tannenbaum

Leave a Comment